New lung scan reveals hidden breathing issues in long COVID sufferers
NCT ID NCT05441657
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study used a special imaging method called electrical impedance tomography (EIT) to look at lung function in 100 people with long COVID who have trouble breathing, compared to 50 healthy volunteers. The goal was to see if EIT can detect changes in how air moves through the lungs. This is an observational study, not a treatment, so it aims to improve understanding rather than test a new therapy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand and detect breathing problems in people with long COVID.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to any direct medical benefit or change in patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
150 people
The number who actually took part.
- Started
-
Apr 2022
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
100 patients with postacute COVID-19 syndrome who present themselves at the outpatient clinic of the University hospital in Jena (JUH) were examined by EIT. 50 lunghealthy volunteers were examined by EIT at JUH.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * for control group: no current lung diseases, over 18 years old * for patients with postacute COVID-19 syndrome: over 18 years, positive SARS-CoV-2-PCR Exclusion Criteria: * heart pacemaker * epilepsy * BMI over 50
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jena university hospital
Jena, Thuringia, 07747, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Transcutaneous vagus nerve stimulation (tVNS) for improved recovery after exertion in patients with Long/Post-COVID.
- REVERSE-Long COVID: a multicenter randomized, Placebo-Controlled clinical trial of immunomodulation (With baricitinib) for long COVID related cognitive impairment and ADRD (Alzheimer's disease and related dementias)
- A single swab, two diseases: rapid test takes on TB and COVID-19
- A central vault for COVID-19 samples could speed up research
- Can a new vaccine bolster defenses against COVID-19?
- Mindfulness may offer relief for long COVID sufferers